A Three Month Bleeding-Model Clinical Study
NCT05916521
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Gingivitis
Interventions
DRUG:
0.454% stannous fluoride
DRUG:
0.76% sodium monofluorophosphate
DRUG:
0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM
Sponsor
Procter and Gamble